Correlation Between Mc Endvrs and Collegium Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mc Endvrs and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mc Endvrs and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mc Endvrs and Collegium Pharmaceutical, you can compare the effects of market volatilities on Mc Endvrs and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mc Endvrs with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mc Endvrs and Collegium Pharmaceutical.

Diversification Opportunities for Mc Endvrs and Collegium Pharmaceutical

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between MSMY and Collegium is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Mc Endvrs and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Mc Endvrs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mc Endvrs are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Mc Endvrs i.e., Mc Endvrs and Collegium Pharmaceutical go up and down completely randomly.

Pair Corralation between Mc Endvrs and Collegium Pharmaceutical

Given the investment horizon of 90 days Mc Endvrs is expected to generate 5.97 times more return on investment than Collegium Pharmaceutical. However, Mc Endvrs is 5.97 times more volatile than Collegium Pharmaceutical. It trades about 0.04 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.01 per unit of risk. If you would invest  0.12  in Mc Endvrs on September 12, 2024 and sell it today you would lose (0.05) from holding Mc Endvrs or give up 41.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.2%
ValuesDaily Returns

Mc Endvrs  vs.  Collegium Pharmaceutical

 Performance 
       Timeline  
Mc Endvrs 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mc Endvrs are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Mc Endvrs showed solid returns over the last few months and may actually be approaching a breakup point.
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Mc Endvrs and Collegium Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mc Endvrs and Collegium Pharmaceutical

The main advantage of trading using opposite Mc Endvrs and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mc Endvrs position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.
The idea behind Mc Endvrs and Collegium Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences